<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980976</url>
  </required_header>
  <id_info>
    <org_study_id>CEIG 2020/375</org_study_id>
    <nct_id>NCT04980976</nct_id>
  </id_info>
  <brief_title>C-MAC Videolaryngoscope for Insertion of a Transesophageal Echocardiography Probe in ICU Patients</brief_title>
  <acronym>VIDLARECO</acronym>
  <official_title>C-MAC Videolaryngoscope for Insertion of a Transesophageal Echocardiography Probe in ICU Patients. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinico Universitario de Santiago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinico Universitario de Santiago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transesophageal echocardiography (TEE) is commonly used in operating room (cardiac surgery),&#xD;
      as well as in other critical care settings. A recent meta-analysis including only three&#xD;
      randomized studies demonstrated that the use of a videolaryngoscope for transesophageal&#xD;
      echocardiography probe insertion in anesthetized patients undergoing open cardiac surgery was&#xD;
      associated with a significant reduction in the number of attempts. insertion and&#xD;
      complications rate, compared with blind insertion or a laryngoscope-assisted insertion.&#xD;
&#xD;
      ICU patients are usually intubated, with multiple complications, requiring high doses of&#xD;
      catecholamines, and with frequent coagulation disorders. Many of these patients, during their&#xD;
      stay in the ICU, require a transesophageal echocardiogram. On multiple occasions, due to the&#xD;
      critical situation of the patients, due to edema, and coagulation alteration, the placement&#xD;
      of the echocardiography probe can be difficult, leading to complications, such as gastric&#xD;
      bleeding or lesions in the oropharyngeal mucosa.&#xD;
&#xD;
      To avoid complications during the insertion of the TEE tube, we consider it necessary to&#xD;
      introduce it in the fewest possible attempts.&#xD;
&#xD;
      The primary aim of the present study was to compare the success rate of TEE probe insertion&#xD;
      at the first attempt betweenn the C-MAC videolaryngoscope assisted insertion and the blind&#xD;
      insertion technique.&#xD;
&#xD;
      The secondary aim was to compared differences between the 2 groups in the incidence of&#xD;
      complications ( oropharyngeal mucosal injury, hematoma, ….), overall success rate, the number&#xD;
      of insertion attempts, and the duration of insertions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred intubated ICU adult patients that require transesophageal echocardiography&#xD;
      insertion, will be randomized by means of a computer-generated randomization order into two&#xD;
      groups: Conventional group (Group Blind), and videolaryngoscope group (group C-MAC).&#xD;
&#xD;
      Success rate of the selected technique (first attempt), overall success rate, number of&#xD;
      attempts, complications, and duration of insertion for technique will be noted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2021</start_date>
  <completion_date type="Anticipated">August 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 19, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>After TEE insertion, the pharyngeal mucosa will be evaluated with de C-MAC videolaryngoscope by an anesthesiologist who were blinded to the study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in the first attempt success rate (percentage)</measure>
    <time_frame>Participants will be followed from the beginning of the transesophageal echocardiography probe insertion through the mouth to the confirmation of successful insertion (10 minutes or three attempts)</time_frame>
    <description>To compare the difference in the first attempt (percentage) of different techniques for insertion of transesophageal echocardiography probe.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in the overall success rate (percentage)</measure>
    <time_frame>Participants will be followed from the beginning of the transesophageal echocardiography probe insertion through the mouth to the confirmation of successful insertion (10 minutes or three attempts)</time_frame>
    <description>To compare the difference overall success rate (percentage) of different techniques for insertion of transesophageal echocardiography probe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in the incidence of complications (percentage)</measure>
    <time_frame>Participants will be followed from the beginning of the transesophageal echocardiography probe insertion through the mouth to the confirmation of successful insertion (10 minutes or three attempts) and in the next 24 hours.</time_frame>
    <description>To compare the difference in complications of different techniques for insertion of transesophageal echocardiography probe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in the duration of insertion</measure>
    <time_frame>Participants will be followed from the beginning of the transesophageal echocardiography probe insertion through the mouth to the confirmation of successful insertion (10 minutes or three attempts) and in the next 24 hour and in the next 24 hours.</time_frame>
    <description>To compare the duration of different techniques for insertion of intransesophageal echocardiography probe.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Other Complications of Surgical and Medical Procedures</condition>
  <arm_group>
    <arm_group_label>Conventional blind insertion technique.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transesophageal echocardiography probe will be inserted using a conventional blind insertion technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C-MAC videolaryngoscope insertion technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transesophageal echocardiography probe will be inserted using a C-MAC videolaryngoscope insertion technique to advance into esophagus under direct vision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blind insertion technique</intervention_name>
    <description>Transesophageal echocardiography probe will be inserted using a conventional blind insertion technique.</description>
    <arm_group_label>Conventional blind insertion technique.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>C-MAC videolaryngoscope insertion technique</intervention_name>
    <description>Transesophageal echocardiography probe will be inserted using a C-MAC videolaryngoscope insertion technique</description>
    <arm_group_label>C-MAC videolaryngoscope insertion technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU intubated patients that require transesophageal echocardiography probe insertion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients younger than 18 years and older than 85 years&#xD;
&#xD;
          -  oropharengeal infection&#xD;
&#xD;
          -  esophageal injury and anatomic abnormalities&#xD;
&#xD;
          -  Consent refusal for participating in the trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuel Taboada</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinical Hospital of Santiago de Compostela</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manuel Taboada, Ph.D.</last_name>
    <phone>+34678195618</phone>
    <email>manutabo@yahoo.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Agustin Cariñena, M.D.</last_name>
    <phone>+34981950674</phone>
    <email>agustincarinena@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Manuel Taboada</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>La Coruña</state>
        <zip>15701</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel L Taboada, Ph.D.</last_name>
      <phone>+34981950674</phone>
      <email>manutabo@yahoo.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Ishida T, Kiuchi C, Sekiguchi T, Tsujimoto T, Kawamata M. McGRATH MAC video laryngoscope for insertion of a transoesophageal echocardiography probe: A randomised controlled trial. Eur J Anaesthesiol. 2016 Apr;33(4):263-8. doi: 10.1097/EJA.0000000000000367.</citation>
    <PMID>26575010</PMID>
  </reference>
  <reference>
    <citation>Kavrut Ozturk N, Kavakli AS. Use of McGrath MAC Videolaryngoscope to Assist Transesophageal Echocardiography Probe Insertion in Intubated Patients. J Cardiothorac Vasc Anesth. 2017 Feb;31(1):191-196. doi: 10.1053/j.jvca.2016.03.150. Epub 2016 Mar 31.</citation>
    <PMID>27498268</PMID>
  </reference>
  <reference>
    <citation>Kumamoto T, Tashima K, Hiraoka C, Ikuta Y, Yamamoto T. McGRATH MAC video laryngoscope assistance during transesophageal echocardiography may reduce the risk of complications: a manikin study. BMC Anesthesiol. 2021 Jan 11;21(1):14. doi: 10.1186/s12871-020-01231-3.</citation>
    <PMID>33430768</PMID>
  </reference>
  <reference>
    <citation>Kim MK, Park SW, Sim Y, Lee JW. Use of a McGrath Videolaryngoscope to assist transesophageal echocardiography probe insertion in anesthetized patients. J Cardiothorac Vasc Anesth. 2015 Apr;29(2):e16-7. doi: 10.1053/j.jvca.2014.09.007. Epub 2014 Dec 24.</citation>
    <PMID>25543216</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 21, 2021</study_first_submitted>
  <study_first_submitted_qc>July 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinico Universitario de Santiago</investigator_affiliation>
    <investigator_full_name>Manuel Taboada Muñiz</investigator_full_name>
    <investigator_title>Ph.D.</investigator_title>
  </responsible_party>
  <keyword>transesophageal; echocardiography; videolaryngoscope;</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data types: Deidentified participant data How to access data: Requests must be sent to manutabo@yahoo.es When available: With publication Additional Information Who can access the data: Researchers whose proposed use of the data has been approved T ypes of analyses: For scientific purpose Mechanisms of data availability: With investigator support</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>When available: With publication</ipd_time_frame>
    <ipd_access_criteria>Researchers whose proposed use of the data has been approved Types of analyses: For scientific purpose</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

